Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04901494
What this trial is testing

SSRI's and the Rate of Progression From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentDementiaAlzheimer Disease
Ohio State University
Not applicableLooking for participantsNCT06179680
What this trial is testing

White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
IRCCS Policlinico S. Donato 142
Not applicableWithdrawnNCT01636596
What this trial is testing

Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Louisiana State University Health Sciences Center Shreveport
Not applicableStudy completedNCT03195894
What this trial is testing

Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care

Who this might be right for
Alcoholism
Kontigo Care AB 115
Testing effectiveness (Phase 2)Looking for participantsNCT04902703
What this trial is testing

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of Colorado, Denver 42
Large-scale testing (Phase 3)UnknownNCT04229927
What this trial is testing

BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

Who this might be right for
Moderate-to-severe Alzheimer's Disease
Hyundai Pharmaceutical Co., LTD. 712
Large-scale testing (Phase 3)Study completedNCT00065767
What this trial is testing

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of Wisconsin, Madison 20
Post-approval studies (Phase 4)UnknownNCT05430867
What this trial is testing

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
TreatmentEfficacySafety+1 more
First Affiliated Hospital Xi'an Jiaotong University 150
Testing effectiveness (Phase 2)Study completedNCT00959192
What this trial is testing

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 32
Not applicableStudy completedNCT00105612
What this trial is testing

Memory Aid for Informed Consent in Alzheimer's Research

Who this might be right for
Alzheimer's DiseaseAging
National Institute on Aging (NIA) 110
Not applicableStudy completedNCT04731311
What this trial is testing

Telerehabilitation Alzheimer's Disease Usability (TADU)

Who this might be right for
Alzheimer DiseaseHealthy Aging
Bright Cloud International Corp 4
Large-scale testing (Phase 3)Study completedNCT04623242
What this trial is testing

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Who this might be right for
Alzheimers DiseaseDementiaAlzheimers Disease, Familial
Washington University School of Medicine 194
Not applicableStudy completedNCT05596994
What this trial is testing

7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Icahn School of Medicine at Mount Sinai 24
Large-scale testing (Phase 3)Ended earlyNCT03114657
What this trial is testing

Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 806
Testing effectiveness (Phase 2)Ended earlyNCT04795466
What this trial is testing

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Novartis Pharmaceuticals 34
Early research (Phase 1)Active Not RecruitingNCT05400330
What this trial is testing

Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Lexeo Therapeutics 10
Not applicableNo Longer AvailableNCT01435551
What this trial is testing

Using Hypnotherapy For Dementia & Alzheimer's

Who this might be right for
Alzheimer Disease
Families To The Rescue
Not applicableLooking for participantsNCT07482072
What this trial is testing

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

Who this might be right for
Alzheimer Dementia (AD)Diabete Type 2
Rigshospitalet, Denmark 60
Not applicableStudy completedNCT05754021
What this trial is testing

A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty

Who this might be right for
FrailtyCognitive ImpairmentDementia+3 more
Baylor College of Medicine 100
Not applicableEnrolling By InvitationNCT06843109
What this trial is testing

Biomarkers in a Candian Memory Clinic

Who this might be right for
Alzheimer's Disease (AD)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100
Next Page